| Q36246201 | A Randomized Trial Examining Housing First in Congregate and Scattered Site Formats |
| Q38779921 | A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder. |
| Q34473088 | A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD) |
| Q36874140 | A comparison of four different approaches to measuring health utility in depressed patients |
| Q37084946 | A comparison of health state utility values associated with oral potentially malignant disorders and oral cancer in Sri Lanka assessed using the EQ-5D-3 L and the EORTC-8D |
| Q51735862 | A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years. |
| Q92786970 | A randomized controlled trial of the effectiveness of Housing First in a small Canadian City |
| Q47173392 | Association of psychological distress, quality of life and costs with carpal tunnel syndrome severity: a cross-sectional analysis of the PALMS cohort |
| Q36111951 | Brief case management versus usual care for frequent users of emergency departments: the Coordinated Access to Care from Hospital Emergency Departments (CATCH-ED) randomized controlled trial |
| Q46536417 | Can EQ-5D and 15D be used interchangeably in economic evaluations? Assessing quality of life in post-stroke patients |
| Q104497552 | Cognitive behavioral therapy for misophonia: A randomized clinical trial |
| Q42604991 | Comparing SF-6D and EQ-5D utilities across groups differing in health status |
| Q48737171 | Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications |
| Q48061844 | Comparison of EQ-5D and SF-6D utilities in Pompe disease. |
| Q44749123 | Comparison of direct-measured and derived short form six dimensions (SF-6D) health preference values among chronic hepatitis B patients |
| Q64236503 | Comparison of the EQ-5D 3L and the SF-6D (SF-36) contemporaneous utility scores in patients with chronic kidney disease in Sri Lanka: a cross-sectional survey |
| Q38647577 | Comparison of the EQ-5D-3L and the SF-6D (SF-12) contemporaneous utility scores in patients with cardiovascular disease. |
| Q92721576 | Comparison of three generic quality-of-life metrics in peripheral arterial disease patients undergoing conservative and invasive treatments |
| Q37292537 | Comparison of three societally derived health-state classification values among older African Americans with depressive symptoms |
| Q35944783 | Construct Validity of the SF-12v2 for the Homeless Population with Mental Illness: An Instrument to Measure Self-Reported Mental and Physical Health |
| Q34116503 | Cost-effectiveness of health promotion targeting physical activity and healthy eating in mental health care |
| Q47550294 | Database Analysis of Depression and Anxiety in a Community Sample-Response to a Micronutrient Intervention |
| Q64100964 | Depression Partially Mediates the Association Between Binge Eating Disorder and Health-Related Quality of Life |
| Q48849298 | Discriminative capacity of the EQ-5D, SF-6D, and SF-12 as measures of health status in population health survey. |
| Q38698926 | Effects of comorbid substance use disorders on outcomes in a Housing First intervention for homeless people with mental illness. |
| Q34414859 | Ending homelessness among people with mental illness: the At Home/Chez Soi randomized trial of a Housing First intervention in Toronto |
| Q33937763 | Estimating a preference-based index from the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM): valuation of CORE-6D |
| Q44671312 | Estimating health utilities in patients with asthma and COPD: evidence on the performance of EQ-5D and SF-6D. |
| Q36575362 | Evaluating the responsiveness of the Warwick Edinburgh Mental Well-Being Scale (WEMWBS): group and individual level analysis |
| Q92910493 | Gender differences among Indigenous Canadians experiencing homelessness and mental illness |
| Q52597281 | Health state utility values of high prevalence mental disorders in Australia: results from the National Survey of Mental Health and Wellbeing. |
| Q40444239 | Housing First for older homeless adults with mental illness: a subgroup analysis of the At Home/Chez Soi randomized controlled trial |
| Q51871557 | How consistent are health utility values? |
| Q58801371 | Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective |
| Q51899117 | Lessons from trial-based cost-effectiveness analyses of mental health interventions: why uncertainty about the outcome, estimate and willingness to pay matters. |
| Q61816572 | Long-term outcome of therapist-guided internet-based cognitive behavioural therapy for body dysmorphic disorder (BDD-NET): a naturalistic 2-year follow-up after a randomised controlled trial |
| Q48575761 | Lowering the 'floor' of the SF-6D scoring algorithm using a lottery equivalent method. |
| Q50562219 | Mapping Sri Lankan EQ-5D-3L to EQ-5D-5L Value Sets. |
| Q51875943 | Measuring and valuing mental health for use in economic evaluation. |
| Q48624644 | Measuring health outcomes of adolescents: report from a pilot study |
| Q36178443 | Preference-based health-related quality-of-life outcomes in children with autism spectrum disorders: a comparison of generic instruments. |
| Q30490626 | Preventing Depression in Adults With Subthreshold Depression: Health-Economic Evaluation Alongside a Pragmatic Randomized Controlled Trial of a Web-Based Intervention |
| Q34296974 | Protocol for economic evaluation alongside a cluster-randomised controlled trial of a psychoeducational intervention for the primary prevention of postnatal mental health problems in first-time mothers |
| Q90548214 | Psychometric properties of the five-level EuroQoL-5 dimension and Short Form-6 dimension measures of health-related quality of life in a population of pregnant women with depression |
| Q51875806 | Putting the 'Q' in depression QALYs: a comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures. |
| Q37511919 | Quality of life impact of mental health conditions in England: results from the adult psychiatric morbidity surveys |
| Q37425353 | Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia |
| Q62384037 | Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses |
| Q37945042 | Systematic review and empirical comparison of contemporaneous EQ-5D and SF-6D group mean scores |
| Q35564873 | The At Home/Chez Soi trial protocol: a pragmatic, multi-site, randomised controlled trial of a Housing First intervention for homeless individuals with mental illness in five Canadian cities |
| Q49048441 | The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common? |
| Q37092449 | The clinical effectiveness of web-based cognitive behavioral therapy with face-to-face therapist support for depressed primary care patients: randomized controlled trial |
| Q38167693 | The estimation of utility weights in cost-utility analysis for mental disorders: a systematic review |
| Q61755509 | The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure |
| Q36246884 | The responsiveness of the EQ-5D and time trade-off scores in schizophrenia, affective disorders, and alcohol addiction |
| Q48263250 | The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression |
| Q35122676 | The validity of the Child Health Utility instrument (CHU9D) as a routine outcome measure for use in child and adolescent mental health services |
| Q59313987 | Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis |
| Q34423176 | Validation and comparison of EuroQoL-5 dimension (EQ-5D) and Short Form-6 dimension (SF-6D) among stable angina patients. |
| Q33864811 | Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders |
| Q48315614 | Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention? |
| Q90011791 | Valuing health using EQ-5D: The impact of chronic diseases on the stock of health |
| Q34493505 | Vancouver At Home: pragmatic randomized trials investigating Housing First for homeless and mentally ill adults |